Why the study?
While bariatric surgery improves non-alcoholic fatty liver disease, similar data regarding the effects of liposuction and abdominoplasty on metabolic parameters and NAFLD course are lacking.
Does liposuction and abdominoplasty improve metabolic parameters and the course of non-alcoholic fatty liver disease in obese patients?
Does liposuction and abdominoplasty improve metabolic parameters and the course of non-alcoholic fatty liver disease in obese patients?
This review highlights a significant gap in the literature regarding the metabolic and hepatic effects of liposuction and abdominoplasty in obese patients with NAFLD, calling for further research.
May improve metabolic profiles in obese NAFLD patients; leaves open long-term disease course effects.
The aim of the study was to study the literature data on the effect of liposuction and abdominoplasty on metabolic parameters and the course of NAFLD. In recent years, technologies for the surgical treatment of obesity have been actively developed, the final stage of which is often liposuction and abdominoplasty. Surgical removal of excess fat mass leads to an improvement in the metabolic profile of patients. In patients with non-alcoholic fatty liver disease on the background of obesity after bariatric interventions, there is a regression of structural and functional changes in the liver. Modern literature convincingly shows the positive effect of bariatric surgery on the course of non-alcoholic fatty liver disease, however, there are no similar data on liposuction and abdominoplasty, which makes further research in this area relevant.
No takes yet. Share an insight, caveat, or question.
Chemso et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: